Radiologists often fail to request patients' informed consent for imaging examinations, and even when they do, many patients are not fully informed about radiation exposure and long-term risk, according to a cardiologist.
Assessing radiological risk is complicated, but doctors must share certain important details with patients, Dr. Eugenio Picano wrote in the British Medical Journal (Oct. 4, 2004;329:849-851). Failure to do so violates basic principles of modern medical practice and disregards patients' rights.
"The language of radiation protection is not readily understood by non-specialists, and it is easy to get lost in a lexicon that expresses radiation doses in megabecquerels and risks as nominal probability coefficients for stochastic effects. The hapless prescribing (and practising) physician who wants to know about radiation risk enters a Tower of Babel, where essential information is 'hidden beneath the veil of verses so obscure,'" wrote Picano, a staff member of the Institute of Clinical Physiology at the National Research Council in Pisa, Italy.
Risk can be communicated to patients by expressing the dose as multiples of a chest x-ray, and the risk of cancer can be explained by the number of extra cases in the exposed population. The U.K. College of Radiologists has suggested this method, and the European Commission had endorsed it. Explanation of dose should be mandatory for the higher risk investigations, Picano said.
"Better knowledge of risks will help us to avoid small individual risks translating into substantial population risks," he said. "Radiological protection should come to mean not just another form to fill in, but a way of thinking, so that long-term risk is familiar to doctors."
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.